If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider Hologic (HOLX) . This company, which is in the Zacks Medical - Instruments industry, shows potential for another earnings beat.When looking at the last two reports, this medical device maker has recorded a strong streak of surpassing earnings estimates. The company has topped estimates by 3.93%, on average, in the last two qua ...

Hologic (HOLX) ended the recent trading session at $76.35, demonstrating a +0.58% swing from the preceding day's closing price. This move lagged the S&P 500's daily gain of 0.63%. Elsewhere, the Dow saw an upswing of 0.2%, while the tech-heavy Nasdaq appreciated by 0.82%.The medical device maker's stock has climbed by 2.87% in the past month, exceeding the Medical sector's gain of 0.91% and the S&P 500's gain of 1.76%.The upcoming earnings release of Hologic will be of great interest to investors. On that d ...

Hologic (HOLX) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future.Shares of this medical device maker have returned +2.1% over the past month versus the Zacks S&P 500 composite's +3.3% change. The Zacks Medical - Instruments industry, to which Hologic belongs, has gained 3.2% over this period. Now the key question is: Where could the stock be headed in the near term?A ...

In the latest market close, Hologic (HOLX) reached $75.64, with a -0.9% movement compared to the previous day. This change lagged the S&P 500's daily gain of 1.12%. Meanwhile, the Dow experienced a rise of 0.61%, and the technology-dominated Nasdaq saw an increase of 1.54%.Prior to today's trading, shares of the medical device maker had gained 3.07% over the past month. This has outpaced the Medical sector's gain of 2.49% and the S&P 500's gain of 2.06% in that time.The investment community will be paying c ...

Hologic, Inc. (HOLX) and its subsidiary, Biotheranostics, recently presented new research findings. The results suggest that in the absence of Breast Cancer Index (BCI) genetic testing, a significant proportion of early-stage hormone receptor-positive (HR+) breast cancer survivors may have received excessive or insufficient treatment. The study was published in the March issue of the JNCCN — Journal of the National Comprehensive Cancer Network.Previous research has shown that most women with early-stage HR+ ...

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) and its subsidiary, Biotheranostics, Inc., today announced newly published study results revealing that use of the Breast Cancer Index® (BCI) test led to physicians changing their long-term anti-estrogen treatment recommendations for 40% of patients with early-stage hormone receptor-positive (HR+) breast cancer.1 The results, which suggest that many women may be over- or undertreated without the incorporation of BCI, reflect real-world data f ...

Hologic (HOLX) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.Over the past month, shares of this medical device maker have returned +1.7%, compared to the Zacks S&P 500 composite's +4.8% change. During this period, the Zacks Medical - Instruments industry, which Hologic falls in, has gained 4.7%. The key question now is: What could be the stock's future direction?Although media repor ...

mapodile/E+ via Getty Images Shares of Hologic (NASDAQ:HOLX) have been trading relatively stagnant in recent years, while the underlying business has seen quite some volatility since the outset of the pandemic. This creates quite an interesting set-up. While lucrative pandemic-related sales are on their retreat, Hologic has seen continued growth, bought back shares and maintained balance sheet discipline. All this has gradually pushed down valuations to quite appealing multiples, amidst solid organic growth ...

Investors interested in Medical - Instruments stocks are likely familiar with Hologic (HOLX) and SONOVA HOLDING (SONVY) . But which of these two stocks offers value investors a better bang for their buck right now? We'll need to take a closer look.There are plenty of strategies for discovering value stocks, but we have found that pairing a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system produces the best returns. The proven Zacks Rank emphasizes companies with pos ...

Hologic, Inc. (HOLX) recently launched new FDA approved Genius Digital Diagnostics System with the Genius Cervical AI algorithm. The launch marks the first and only FDA-cleared digital cytology system that combines deep-learning-based artificial intelligence (AI) with advanced volumetric imaging technology to help identify pre-cancerous lesions and cervical cancer cells.According to American Cancer Society's most current projection, 4,360 women would lose their lives to invasive cervical cancer in the Unite ...